Shoppers Drug Mart, Canada’s largest pharmacy chain, has submitted an application to Health Canada to distribute marijuana for medical use.
In a statement, Shoppers Drug Mart Spokesperson Tammy Smitham said that the application they submitted was strictly for distribution and not production of medical marijuana. She says Shoppers Drug Mart wants “the ability to dispense medical marijuana to our patients in conjunction with counselling from a pharmacist.”
Smitham also emphasized that dispensing medical marijuana at Shoppers Drug Mart would increase safety and security for users because of the face-to-face interaction between patient and pharmacist. As of the end of June, there are a total of 75,166 number of medical marijuana clients — a huge market that the Canadian pharmacy giant can tap into.
Medical marijuana delivery by mail
However, under the current rules, CTV news says that Shoppers Drug Mart’s application does not mean it can sell medical marijuana in stores. Current rules state that registered patients can only purchase cannabis directly from producers. The product is then sent to the clients via mail.
If the Shoppers Drug Mart application goes through and is approved, it would require new or revised rules to allow pharmacists to fill prescriptions in person in retail stores.
Aurora Cannabis (OTCMARKETS:ACBFF) Senior Vice President Cam Battley said that news of Shoppers Drug Mart entering the cannabis arena is, “a clear validation of medical cannabis and a clear indication of massive patient demand.”
Huge upside in the marijuana market
The economic upside to the marijuana market is huge, estimated to be between $80 and $100 million per year for 45,000 medical marijuana users. Investors have certainly welcomed this, as marijuana stocks continue to register positive gains.
Changes in legislation forthcoming
Although it is known that the Canadian Federal Government’s Task Force on Marijuana Legalization and Regulation is expected to report back to the government in November, no one is for sure what the changes will be, although it is anticipated that the changes will cover both medical and recreational marijuana.
Until then, continue to watch this space to see future developments.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Pia Rivera, hold no direct investment interest in any company mentioned in this article.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).